PICKERING, ON, Oct. 27, 2014 /CNW/ - Purdue Pharma Canada today announced the appointment of Ms. Kelly Martin as Vice President, Finance and Chief Financial Officer.
Kelly brings 25 years of financial and management experience from her tenure in various executive positions. Most recently, she was Vice President Finance & Logistics at Janssen Inc. (Canada), a division of Johnson & Johnson Inc. Kelly is known for her ability to provide leadership during times of change, with a strong commitment to long-term success.
"Effectively leading the function will require meaningful insight and assessment of potential diversification, as well as prudent management of the financial elements of the business," said Dr. Craig Landau, president and CEO of Purdue Pharma Canada. "With Kelly's combined leadership and financial expertise within the pharmaceutical industry, she will be instrumental in contributing to the overall success of the company."
Kelly earned a Bachelor of Commerce (B.Comm.) degree from the University of Toronto in 1990. She qualified as a Chartered Professional Accountant in March of 1993.
About Purdue Pharma Canada
Purdue Pharma (www.purdue.ca) is a research-based pharmaceutical company with its headquarters and manufacturing operations located in Pickering, Ontario. The company is a leader in the research and development of medicines for the treatment of pain and ADHD. Privately held, Purdue Pharma Canada is independently associated with the worldwide Purdue/Napp/Mundipharma group of companies.
Image with caption: "Kelly A. Martin, Vice President, Finance and Chief Financial Officer, Purdue Pharma Canada (CNW Group/Purdue Pharma)". Image available at: http://photos.newswire.ca/images/download/20141027_C2507_PHOTO_EN_7069.jpg
SOURCE: Purdue Pharma
For further information: Lucy Lai, 905 420-6400, [email protected]